Fasting C-peptide levels and death resulting from all causes and breast cancer: the health, eating, activity, and lifestyle study.
about
Epithelial cancers in the post-genomic era: should we reconsider our lifestyle?The peroxisome proliferator-activated receptor (PPAR) α agonist fenofibrate suppresses chemically induced lung alveolar proliferative lesions in male obese hyperlipidemic mice.Hyperinsulinemia promotes metastasis to the lung in a mouse model of Her2-mediated breast cancer.Metabolic syndrome in breast cancer.Association of serum C-peptide concentrations with cancer mortality risk in pre-diabetes or undiagnosed diabetes.The Role of the Insulin/IGF System in Cancer: Lessons Learned from Clinical Trials and the Energy Balance-Cancer Link.Metabolic syndrome and triple-negative breast cancer: a new paradigm.Use of Insulin and Mortality from Breast Cancer among Taiwanese Women with DiabetesBootcamp during neoadjuvant chemotherapy for breast cancer: a randomized pilot trial.Obesity and Diabetes: The Increased Risk of Cancer and Cancer-Related Mortality.Long-Term Follow-Up of the E1199 Phase III Trial Evaluating the Role of Taxane and Schedule in Operable Breast Cancer.The insulin receptor: a new target for cancer therapy.Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer.The role of obesity in cancer survival and recurrence.Insulin therapy and cancer in type 2 diabetes.The soybean peptide lunasin promotes apoptosis of mammary epithelial cells via induction of tumor suppressor PTEN: similarities and distinct actions from soy isoflavone genisteinFasting serum C-peptide levels predict cardiovascular and overall death in nondiabetic adultsExamining the relationship between diet-induced acidosis and cancer.C-peptide levels are associated with mortality and cardiovascular mortality in patients undergoing angiography: the LURIC study.Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancer.A twenty-first century cancer epidemic caused by obesity: the involvement of insulin, diabetes, and insulin-like growth factorsMetabolic syndrome and pre-diabetes contribute to racial disparities in breast cancer outcomes: hypothesis and proposed pathways.Diabetes, metformin, and breast cancer in postmenopausal womenEpidemiology and molecular mechanisms tying obesity, diabetes, and the metabolic syndrome with cancer.The association between adiposity and breast cancer recurrence and survival: A review of the recent literatureBody mass index and circulating oestrone sulphate in women treated with adjuvant letrozole.Importance of metabolic changes induced by chemotherapy on prognosis of early-stage breast cancer patients: a review of potential mechanisms.Insulinemia and the risk of breast cancer and its relapse.C-Peptide and its career from innocent bystander to active player in diabetic atherogenesis.Insulin and IGFs in obesity-related breast cancer.Repositioning metformin in cancer: genetics, drug targets, and new ways of delivery.Smartphone-Enabled Health Coaching Intervention (iMOVE) to Promote Long-Term Maintenance of Physical Activity in Breast Cancer Survivors: Protocol for a Feasibility Pilot Randomized Controlled Trial.Hyperinsulinaemia and insulin signalling in the pathogenesis and the clinical course of hepatocellular carcinoma.OP449 inhibits breast cancer growth without adverse metabolic effects.Impact of race, ethnicity, and BMI on achievement of pathologic complete response following neoadjuvant chemotherapy for breast cancer: a pooled analysis of four prospective Alliance clinical trials (A151426).Recent advances in the use of metformin: can treating diabetes prevent breast cancer?Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance A011401): study design.Influence of body mass index on clinicopathological factors including estrogen receptor, progesterone receptor, and Ki67 expression levels in breast cancers.Influence of diabetes mellitus on mortality in breast cancer patients.Genetic variation in TNFα, PPARγ, and IRS-1 genes, and their association with breast-cancer survival in the HEAL cohort.
P2860
Q28391921-F68AFD08-781C-4A58-83F1-FE360698EE17Q33755975-BEEFB5A9-B248-42DA-BE2D-A2EE90D3015DQ33887610-57E92508-32AE-43B3-A016-2ED4BC319D19Q33973037-E830F941-C31F-499B-8523-E1F8F40BB12EQ34584370-57CD02ED-0E03-4913-8004-9457E6FA76ABQ35609517-D635A24C-3661-48B6-BCE2-D72C13A73050Q35684565-52E164B5-E305-423B-BB5C-C1EC2298CF60Q35782192-0993D2E2-FED9-4BAE-AE36-5DD0991F6C9DQ35789677-BDEFB48B-472C-4F73-BB9F-14033304523FQ35817986-0F0BC4BD-2E40-4541-90A8-6D868CFBA3AFQ35847450-1D930204-6C6D-461B-B5B0-F6B6BB7BD0BEQ35972002-73822540-E5F1-45F1-BA87-47C88658486BQ36070998-CB3D6923-E321-45BA-972D-E1366C798F76Q36152955-8C75483A-BE33-449B-A84E-A960B7A43846Q36417868-B0DF8C6E-4963-4BE4-B991-97EEB961C658Q36502037-E8551305-5BB9-4532-A3AF-0A0E4929DDDCQ36519849-3BABE88A-F8F9-43FC-A396-D8917B9C4649Q36608481-857D73F1-ED12-496C-B937-A7EF756CB57BQ36629649-83BAD085-000F-452B-AF0D-846BEBBA41D7Q36650415-004029A5-DE29-43EB-B40D-6B688CC790F3Q37105231-2DB7F5D3-6816-4597-A5A6-32D4AF45B4A9Q37191427-86782F55-D848-48A5-AE65-8BDC81D99231Q37303867-7B854A0A-7BCB-4C38-9A75-966B83EEB548Q37577156-7D40FFCF-D4A8-4C3B-8989-D9107FC52BB3Q37579337-706AF86A-7304-4E4D-BB02-D561C7AAD985Q37632155-C529C229-7095-40D5-8683-4D70B9370DF0Q37963505-6F900219-A93F-486F-8791-B46581E923A8Q38005770-B3BD0E1F-8F76-43F2-9BE1-B2164F47B032Q38112357-5F70A83D-7663-4A28-96F1-5B2CB6D0AA24Q38155073-F7A458EE-7C3B-4209-B57B-3DD089A32CAFQ38185970-C4445689-BB28-4AE4-B076-E34B74986562Q38372159-E5831553-9B75-4205-916C-EA2985EF8BA2Q38540380-90080F90-47A6-4BF7-B8FF-C09C08F6AF03Q38613399-B9E8742D-2589-473A-B255-975DEDA1A23EQ39568666-8ECCE9C3-9BFC-4F01-A8BC-0077B4640070Q41083568-D9B40005-532C-4D3F-96FB-C0B20718B239Q41693904-8EDA394E-EEF7-4539-987A-945D7DD84B70Q43948558-10C6C433-30A2-49A0-99B5-639A6F2C7D8EQ45908971-3A56CCE0-C0E5-4E3B-88B6-D0BE41E8DE60Q47285112-30FBE6B1-D7C3-4258-99DA-318958455423
P2860
Fasting C-peptide levels and death resulting from all causes and breast cancer: the health, eating, activity, and lifestyle study.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Fasting C-peptide levels and d ...... activity, and lifestyle study.
@ast
Fasting C-peptide levels and d ...... activity, and lifestyle study.
@en
Fasting C-peptide levels and d ...... activity, and lifestyle study.
@nl
type
label
Fasting C-peptide levels and d ...... activity, and lifestyle study.
@ast
Fasting C-peptide levels and d ...... activity, and lifestyle study.
@en
Fasting C-peptide levels and d ...... activity, and lifestyle study.
@nl
prefLabel
Fasting C-peptide levels and d ...... activity, and lifestyle study.
@ast
Fasting C-peptide levels and d ...... activity, and lifestyle study.
@en
Fasting C-peptide levels and d ...... activity, and lifestyle study.
@nl
P2093
P2860
P356
P1476
Fasting C-peptide levels and d ...... activity, and lifestyle study.
@en
P2093
Anne McTiernan
Ashley Wilder Smith
Catherine Duggan
Ching-Yun Wang
Kathy B Baumgartner
Melinda L Irwin
Richard N Baumgartner
P2860
P356
10.1200/JCO.2010.28.4752
P407
P577
2010-11-29T00:00:00Z